Complete News World

How Vadis, Danube?  The Danube River between protection and use

How Vadis, Danube? The Danube River between protection and use

February 19, 2024, 937 characters

Vienna (OTS) – Quo vadis, Danube? The Danube River between protection and use

Discuss it:

Verena Finnewarter, environmental historian Helmut Habersack, former head of the CD Laboratory for Innovative Methods in River Monitoring, Modeling and River Engineering. Georg Schäuble, Spokesman for the Management Board and Member of the Management Board for Finance and Lands of the Austrian Federal Forest AG Thomas Heine, Head of the CD Laboratory for Meta-ecosystem Dynamics in Regulated River Landscapes Hans-Peter Hasenbichler, Managing Director of via donau – Österreichische Wasserstraßen GmbH and Member of the Management Board CDG Karl-Heinz Gruber, Managing Director of Verbund Hydro Power GmbH

Welcome and closing: Martin Jerzabek, Head of CDG Administration: Martin Kugler, Science Journalist

Date: February 28, 2024, 6:00 PM – 7:30 PM Location: APA Press Center Laimgrubengasse 8-10, 1060 Vienna URL:…

BSN Podcast

Christian Drastl: Vienna Stock Exchange Chat

Vienna Stock Exchange Party No. 591: Vienna Airport invites you, a great idea was sent to the stock exchange passengers by email, and Erste's special support went

Stocks on the radar:Do & Share, Rosenbauer, Federal Communications Commission, Austriacard Holdings AG, Adecco Bank, Amaj, rosegx, Fig, Bor, Uniqa, OMV, AT&S, ams-osram, Frequencies, Marinomed Biotechnology, Stadlauer Melzfabrik AG, Zumtobel, SW Environmental Technology, Oberbank AG Fund, Strabag, We were tempted, California real estate, The first group, AVN, Vienna Airport, Mortgage, Capsh Traffic com, Austrian Post, Telekom Austria, Weinerberger.

See also  nShift: Generates Branded Packaging 'Recommendations' in Retail

Random partners

Croma Pharma® is an Austrian family company based in Leobendorf. The company specializes in the industrial production of hyaluronic acid injections and is one of the leading companies in Europe in this field. The company is focusing on the growth segment of minimally invasive aesthetic medicine through its own brands.

>> Visit 68 other partners at

More current OTS reports here